Axsome Therapeutics, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · New York, NY
AXSM chart
What traders are saying about $AXSM
Latest postsAxsome Therapeutics, Inc. news
- Axsome Therapeutics Gains as Strong Quarterly Growth and Auvelity Momentum Stay in Focus
Quiver Quantitative ·
- Axsome Therapeutics (NASDAQ:AXSM) Stock Price Up 5.9% - Time to Buy?
MarketBeat ·
- Axsome Therapeutics, Inc. $AXSM Stock: Pictet Asset Management Holding SA Raises Holdings
MarketBeat ·
- Axsome Therapeutics Tops $1 Billion Revenue Run Rate as AUVELITY Sales Surge
marketbeat.com ·
- How Narrower Losses Will Impact Axsome Therapeutics Stock Investors
Simply Wall St ·
- H.C. Wainwright Maintains Axsome Therapeutics(AXSM.US) With Buy Rating, Maintains Target Price $290
Moomoo ·
- Weekly Recap: Q3 revenue tops estimates and shares hit 52-week low
TradingView ·
- Is Axsome Therapeutics (AXSM) Fully Priced Given Its Sales Growth?
Yahoo Finance ·
- Axsome Therapeutics Stock Price Forecast. Should You Buy AXSM?
StockInvest.us ·
- Axsome Therapeutics (AXSM) Stock May Be Reasonable On Strong Q3 Revenue Growth
Simply Wall St ·
- Axsome Therapeutics Inc (19X.MU) Seasonal returns chart
Yahoo Finance Singapore ·
- Axsome Therapeutics (AXSM) Stock Gets Fair Value Trim After Q3 Analyst Revisions
Yahoo Finance ·
Axsome Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $638.5M | $385.7M | $270.6M | $50.0M |
| Net income | -$183.2M | -$287.2M | -$239.2M | -$187.1M |
| Diluted EPS | $-3.68 | $-5.99 | $-5.27 | $-4.60 |
| Total assets (year end) | $689.8M | $568.5M | $588.2M | $331.5M |
| Cash and equivalents (year end) | $322.9M | $315.4M | $386.2M | $200.8M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Axsome Therapeutics, Inc.
- Ticker
- AXSM (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- New York, NY
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1579428
Frequently asked questions
What exchange is Axsome Therapeutics, Inc. listed on?
Axsome Therapeutics, Inc. trades on the Nasdaq under the ticker symbol AXSM.
What industry is Axsome Therapeutics, Inc. in?
Axsome Therapeutics, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Axsome Therapeutics, Inc. headquartered?
Axsome Therapeutics, Inc.'s business address on file with the SEC is in New York, NY.
When does Axsome Therapeutics, Inc.'s fiscal year end?
Axsome Therapeutics, Inc.'s fiscal year ends on December 31.
How much revenue did Axsome Therapeutics, Inc. report?
Axsome Therapeutics, Inc. reported $638.5M in revenue for calendar year 2025, according to its SEC filings.